Ulti_1170x120_5-11-20

Viatris

Viatris reveals branding to reflect new company’s transformative strategy

Viatris reveals branding to reflect new company’s transformative strategy

HERTFORDSHIRE, England— Mylan and Upjohn, a division of Pfizer, unveiled on Thursday the logo and branding for Viatris, the new company that will be formed by combining Mylan and Upjohn.  Viatris will benefit from Mylan and Upjohn’s trusted global offerings and legacy of meeting patient needs around the world. The new logo and branding is

Mylan shareholders approve proposed combination with Upjohn

Mylan shareholders approve proposed combination with Upjohn

HERTFORDSHIRE, England  – Mylan announced that its shareholders overwhelmingly voted to approve the proposed transaction combining Mylan and Upjohn, a division of Pfizer, at the company’s extraordinary general meeting of shareholders. Approximately 99.6% of votes cast were voted in favor of the combination. Mylan executive chairman and future Viatris executive chairman Robert Coury said: “The

Mylan, Pfizer announce Viatris as the new company name 

Mylan, Pfizer announce Viatris as the new company name 

NEW YORK — Mylan and Pfizer  announced earlier this week that the name of the new company to be formed by the planned combination of Mylan and Upjohn, a division of Pfizer, will be Viatris (pronounced ‘viǝ-trīs). Deriving its name from Latin, Viatris embodies the new company’s goal of providing a path—“VIA”—to three—“TRIS”—core goals: expanding